JP2009508658A5 - - Google Patents

Download PDF

Info

Publication number
JP2009508658A5
JP2009508658A5 JP2008532392A JP2008532392A JP2009508658A5 JP 2009508658 A5 JP2009508658 A5 JP 2009508658A5 JP 2008532392 A JP2008532392 A JP 2008532392A JP 2008532392 A JP2008532392 A JP 2008532392A JP 2009508658 A5 JP2009508658 A5 JP 2009508658A5
Authority
JP
Japan
Prior art keywords
matrix
composition
natural biodegradable
article
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008532392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009508658A (ja
JP5226518B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/036861 external-priority patent/WO2007035886A1/en
Publication of JP2009508658A publication Critical patent/JP2009508658A/ja
Publication of JP2009508658A5 publication Critical patent/JP2009508658A5/ja
Application granted granted Critical
Publication of JP5226518B2 publication Critical patent/JP5226518B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008532392A 2005-09-21 2006-09-21 天然の生分解性マトリックス、及びその使用 Expired - Fee Related JP5226518B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71946605P 2005-09-21 2005-09-21
US60/719,466 2005-09-21
PCT/US2006/036861 WO2007035886A1 (en) 2005-09-21 2006-09-21 Natural biodegradable matrices and uses thereof

Publications (3)

Publication Number Publication Date
JP2009508658A JP2009508658A (ja) 2009-03-05
JP2009508658A5 true JP2009508658A5 (enExample) 2009-11-12
JP5226518B2 JP5226518B2 (ja) 2013-07-03

Family

ID=36958998

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008532203A Expired - Fee Related JP5139301B2 (ja) 2005-09-21 2005-11-11 生分解性天然多糖を含む被膜及び器具
JP2008532392A Expired - Fee Related JP5226518B2 (ja) 2005-09-21 2006-09-21 天然の生分解性マトリックス、及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008532203A Expired - Fee Related JP5139301B2 (ja) 2005-09-21 2005-11-11 生分解性天然多糖を含む被膜及び器具

Country Status (7)

Country Link
US (4) US8241656B2 (enExample)
EP (2) EP1926509B1 (enExample)
JP (2) JP5139301B2 (enExample)
CN (3) CN101309709A (enExample)
AT (2) ATE540705T1 (enExample)
CA (2) CA2621595A1 (enExample)
WO (2) WO2007040557A1 (enExample)

Families Citing this family (161)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5048201B2 (ja) 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
CN101134119A (zh) 2002-05-24 2008-03-05 血管技术国际股份公司 用于涂覆医用植入物的组合物和方法
US8313760B2 (en) * 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
CN102210852B (zh) 2003-05-15 2016-10-19 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
WO2005113034A1 (en) * 2004-05-12 2005-12-01 Surmodics, Inc. Natural biodegradable polysaccharides coatings for medical articles
US9452001B2 (en) * 2005-02-22 2016-09-27 Tecres S.P.A. Disposable device for treatment of infections of human limbs
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
WO2007038126A1 (en) * 2005-09-21 2007-04-05 Surmodics, Inc. In vivo formed matrices including natural biodegradable polysaccharides and ophthalmic uses thereof
CA2621595A1 (en) * 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
WO2007059144A1 (en) * 2005-11-15 2007-05-24 Surmodics, Inc. Ultrasonic nozzles for applying two-component coatings
WO2007059528A2 (en) * 2005-11-17 2007-05-24 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
US7943242B2 (en) 2006-03-30 2011-05-17 Becton, Dickinson And Company Sealing members, articles using the same and methods of reducing sticktion
US8075995B2 (en) * 2006-03-30 2011-12-13 Becton, Dickinson And Company Coating system, articles and assembly using the same and methods of reducing sticktion
US8486135B2 (en) 2006-06-01 2013-07-16 Abbott Cardiovascular Systems Inc. Implantable medical devices fabricated from branched polymers
US8968782B2 (en) * 2006-06-28 2015-03-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
US20090305089A1 (en) * 2006-07-14 2009-12-10 Akermin, Inc. Organelles in bioanodes, biocathodes, and biofuel cells
BRPI0715054A2 (pt) * 2006-07-28 2013-05-28 Biograde Hong Kong Pty Ltda mÉtodo para preparar uma composiÇço de polÍmero biodegradÁvel, mistura padrço, mÉtodo para preparar a mesma, e, composiÇço de polÍmero biodegradÁvel
WO2008022258A2 (en) * 2006-08-16 2008-02-21 Surmodics, Inc. Methods and materials for increasing the adhesion of elution control matrices to substrates
US20080075753A1 (en) * 2006-09-25 2008-03-27 Chappa Ralph A Multi-layered coatings and methods for controlling elution of active agents
WO2008088593A2 (en) * 2006-09-27 2008-07-24 Surmodics, Inc. Additives and methods for enhancing active agent elution kinetics
US20080114096A1 (en) * 2006-11-09 2008-05-15 Hydromer, Inc. Lubricious biopolymeric network compositions and methods of making same
ES2473620T3 (es) * 2007-02-06 2014-07-07 Hisamitsu Pharmaceutical Co., Inc. Dispositivo de microagujas para el diagnóstico de una alergia
WO2009005718A1 (en) * 2007-06-28 2009-01-08 Surmodics, Inc. Polypeptide microparticles having sustained release characteristics, methods and uses
US20110137243A1 (en) * 2007-09-06 2011-06-09 Abbott Cardiovascular Systems Inc. Coating On A Balloon Device
WO2009038783A1 (en) * 2007-09-19 2009-03-26 Surmodics, Inc. Biocompatible foams, systems, and methods
WO2009042231A2 (en) * 2007-09-27 2009-04-02 Akina, Inc. Sol-gel phase-reversible hydrogel templates and uses thereof
US20090214601A1 (en) * 2007-09-28 2009-08-27 Chappa Ralph A Porous Drug Delivery Devices and Related Methods
ES2623456T3 (es) * 2007-10-19 2017-07-11 Interface Biologics Inc. Recubrimientos autoeliminantes
US20110091862A1 (en) * 2007-11-14 2011-04-21 Osteosphere, Llc Generation of an hla-negative osteogenic precursor cell line
WO2009064957A1 (en) * 2007-11-14 2009-05-22 Osteosphere, Llc Development of a human colloidal bone graft material
EP2067494A1 (en) * 2007-12-04 2009-06-10 Charité-Universitätsmedizin Berlin Sheet or tubular structure consisting of elastic biocompatible material and its use
JP2011509944A (ja) * 2008-01-14 2011-03-31 サーモディクス，インコーポレイティド 核酸送達複合体の溶出のための装置及び方法
US8109908B1 (en) 2008-01-22 2012-02-07 Greatbatch Ltd. Biodegradable shroud for a dilator/sheath assembly
US8173222B2 (en) * 2008-03-14 2012-05-08 Spencer Brody Controlled degradability of organic materials
WO2009126830A2 (en) * 2008-04-09 2009-10-15 Surmodics, Inc. Delivery of nucleic acid complexes from materials including negatively charged groups
CA2722425A1 (en) * 2008-04-28 2009-11-05 Surmodics, Inc. Poly-.alpha.(1-4)glucopyranose-based matrices with hydrazide crosslinking
DE102008021894A1 (de) * 2008-05-02 2009-11-05 Biotronik Vi Patent Ag Implantat umfassend eine Oberfläche mit verringerter Thrombogenität
JP5763525B2 (ja) 2008-05-07 2015-08-12 サーモディクス，インコーポレイティド 粒子からの核酸複合体の送達
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
JP5340823B2 (ja) * 2008-06-24 2013-11-13 ナガセ医薬品株式会社 医療用潤滑剤
EP2306929A1 (en) * 2008-07-14 2011-04-13 SurModics, Inc. Medical devices and methods for delivery of nucleic acids
US8114429B2 (en) 2008-09-15 2012-02-14 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US9198968B2 (en) 2008-09-15 2015-12-01 The Spectranetics Corporation Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8128951B2 (en) 2008-09-15 2012-03-06 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8257722B2 (en) 2008-09-15 2012-09-04 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US20100124568A1 (en) * 2008-11-20 2010-05-20 Med-Eez, Inc Pharmaceutical articles coated with lubricious coatings
CA2758260A1 (en) * 2009-04-08 2010-10-14 Surmodics, Inc. Controlled release devices and methods for delivery of nucleic acids
WO2010118213A2 (en) 2009-04-08 2010-10-14 Surmodics, Inc. Particles for delivery of nucleic acids and related devices and methods
US9155815B2 (en) 2009-04-17 2015-10-13 Tenaxis Medical, Inc. Biocompatible phase invertible proteinaceous compositions and methods for making and using the same
US20100280594A1 (en) * 2009-05-01 2010-11-04 Medi-Solve, Llc Antithrombotic Neurovascular Device Containing a Glycoprotein IIB/IIIA Receptor Inhibitor for The Treatment of Brain Aneurysms and/or Acute Ischemic Stroke, and Methods Related Thereto
US8246576B2 (en) 2009-05-18 2012-08-21 Surmodics, Inc. Method and apparatus for delivery of a therapeutic agent with an expandable medical device
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
JP5937004B2 (ja) 2009-05-18 2016-06-22 ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 薬剤溶出眼内インプラント
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
DE102009022805B4 (de) 2009-05-27 2013-04-25 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Polysaccharidestern oder Polysaccharidmischestern
US20100303878A1 (en) * 2009-06-02 2010-12-02 Joram Slager Biodegradable bioactive agent releasing matrices with particulates
US8586731B2 (en) * 2009-06-11 2013-11-19 Surmodics, Inc. Hydrophobic polysaccharides with diester- or carbonate ester-containing linkages having enhanced degradation
US8986377B2 (en) 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
US20110046721A1 (en) * 2009-08-10 2011-02-24 Surmodics, Inc. Biodegradable Metal-Polymer Composite Constructs For Implantable Medical Devices
EP2301595B1 (en) * 2009-09-23 2014-01-22 Dentsply IH AB Flushable catheter and method for producing such a catheter
US8932616B2 (en) * 2009-09-30 2015-01-13 Surmodics, Inc. Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom
EP2513225A4 (en) 2009-12-18 2015-08-12 Interface Biologics Inc LOCAL ACTIVE INGREDIENT RELIEF FROM SELF-ORDINATED COATINGS
US8568760B2 (en) * 2009-12-30 2013-10-29 Surmodics, Inc. Hydrophobic polysaccharides with pendent groups having terminal reactive functionalities and medical uses thereof
CA2794958A1 (en) 2010-03-29 2011-10-06 Surmodics, Inc. Injectable drug delivery formulation
JP5945534B2 (ja) 2010-05-10 2016-07-05 サーモディクス，インコーポレイテッド グリセロールエステル活性剤送達システムおよび方法
US20110319473A1 (en) 2010-06-29 2011-12-29 Surmodics, Inc. Compositions and methods for enhancement of nucleic acid delivery
JP5984806B2 (ja) * 2010-06-30 2016-09-06 サーモディクス，インコーポレイティド 生体活性剤を送達する医療デバイスのための脂質コーティング
US9295663B2 (en) 2010-07-14 2016-03-29 Abbott Cardiovascular Systems Inc. Drug coated balloon with in-situ formed drug containing microspheres
US20120100187A1 (en) 2010-10-26 2012-04-26 Surmodics, Inc. Coatings and methods for controlled elution of hydrophilic active agents
US9668915B2 (en) 2010-11-24 2017-06-06 Dose Medical Corporation Drug eluting ocular implant
DE112011104252A5 (de) * 2010-12-04 2013-10-17 Alexander Rübben Beschichtung und Beschichtungsverfahren für den Ballon eines Ballonkatheters sowie Ballonkatheter mit beschichtetem Ballon
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
WO2012092566A1 (en) * 2010-12-30 2012-07-05 Surmodics, Inc. Cell attachment coatings and methods
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
US9861727B2 (en) * 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
GB201112407D0 (en) * 2011-07-19 2011-08-31 Neoss Ltd Surface treatment process for implantable medical device
JP2014530063A (ja) 2011-10-10 2014-11-17 アンピオ ファーマシューティカルズ，インコーポレイテッド 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
PH12014500685B1 (en) 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
HK1198812A1 (en) 2011-10-28 2015-06-12 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US9549812B2 (en) 2012-01-13 2017-01-24 Lifecell Corporation Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses
CN104168927B (zh) 2012-03-27 2016-10-05 泰尔茂株式会社 涂布组合物及医疗器械
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
DE102012010800A1 (de) * 2012-06-01 2013-12-05 Alexander Rübben Beschichtung von Ballonkathetern
CA2874824C (en) 2012-06-01 2021-10-26 Surmodics, Inc. Apparatus and methods for coating balloon catheters
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
US9631190B2 (en) 2012-06-29 2017-04-25 Surmodics, Inc. Cell attachment coatings and methods using phosphorous-containing photoreagent
US10519434B2 (en) 2012-07-13 2019-12-31 Diomics Corporation Biologic sample collection devices and methods of production and use thereof
US8759075B2 (en) * 2012-07-13 2014-06-24 Diomics Corporation Biologic sample collection devices and methods of production and use thereof
US9708600B2 (en) * 2012-07-13 2017-07-18 Diomics Corporation Biologic sample collection devices and methods of production and use thereof
CN102827770A (zh) * 2012-08-20 2012-12-19 三峡大学 一种筛选淀粉酶产生菌的显色方法
US20140105956A1 (en) * 2012-10-11 2014-04-17 Rupak BANERJEE Biodegradable polymer based microimplant for ocular drug delivery
US9155671B2 (en) 2012-10-16 2015-10-13 Surmodics, Inc. Wound packing device and methods
US11090468B2 (en) 2012-10-25 2021-08-17 Surmodics, Inc. Apparatus and methods for coating medical devices
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
WO2014071387A1 (en) 2012-11-05 2014-05-08 Surmodics, Inc. Composition and method for delivery of hydrophobic active agents
CA2891118C (en) 2012-11-12 2017-07-04 Hollister Incorporated Intermittent catheter assembly and kit
AU2013345395B2 (en) 2012-11-14 2017-02-23 Hollister Incorporated Disposable catheter with selectively degradable inner core
NL2010040C2 (en) * 2012-12-21 2014-06-24 Internat Inst For Diagnostic And Analitical Affairs B V Cleavable coating material having microbial functionality.
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
GB2514592A (en) * 2013-05-30 2014-12-03 Medtrade Products Ltd Degradable haemostat composition
US9446431B2 (en) 2013-08-15 2016-09-20 Cook Medical Technologies Llc Hydrophilic coatings and methods for coating medical devices with hydrophilic coatings
ES2869024T3 (es) 2013-11-08 2021-10-22 Hollister Inc Catéteres oleófilos lubricados
LT3079749T (lt) 2013-12-12 2019-12-27 Hollister Incorporated Srove nuplaunami kateteriai
EP3079752B1 (en) 2013-12-12 2020-04-01 Hollister Incorporated Flushable catheters
LT3079750T (lt) 2013-12-12 2020-07-27 Hollister Incorporated Srove nuplaunami kateteriai
HUE051635T2 (hu) 2013-12-12 2021-03-01 Hollister Inc Toalettben lehúzható szétmálló katéter
US10525171B2 (en) 2014-01-24 2020-01-07 The Spectranetics Corporation Coatings for medical devices
EP3166726A4 (en) 2014-05-01 2018-03-07 Diomics Corporation Devices and kits for collection, storage and analysis of samples and methods of production and use thereof
AU2015266850B2 (en) 2014-05-29 2019-12-05 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10470712B2 (en) * 2014-06-19 2019-11-12 Sipple Medical, Llc Biomarker detection and identification system and apparatus
US20160025603A1 (en) 2014-07-22 2016-01-28 Diomics Corporation Airborne agent collectors, methods, systems and devices for monitoring airborne agents
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10346671B2 (en) 2014-08-15 2019-07-09 Diomics Corporation Films for biologic analyte collection and analysis and methods of production and use thereof
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US10850274B2 (en) * 2015-04-10 2020-12-01 The Regents Of The University Of California Microfluidic assisted perfusion devices
US10702688B2 (en) 2015-05-11 2020-07-07 Access For Life Inc. Vascular access device
HK1253775A1 (zh) 2015-05-15 2019-07-05 Lifecell Corporation 用於整形外科的组织模型
DK3310404T3 (da) 2015-06-17 2024-03-25 Hollister Inc Selektivt vanddesintegrerbare materialer og katetre fremstillet af sådanne materialer
AU2016280546B2 (en) 2015-06-17 2020-04-30 Hollister Incorporated Water disintegrable flushable catheter
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
WO2017034952A1 (en) 2015-08-21 2017-03-02 Lifecell Corporation Breast treatment device
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
CA2998170C (en) 2015-09-15 2023-10-03 Savage Medical, Inc. Devices and methods for anchoring a sheath in a tissue cavity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
US12102973B2 (en) 2015-12-18 2024-10-01 Safeguard Biosystems Holdings Ltd. Three-dimensional polymer networks with channels situated therein
EP3181700A1 (en) * 2015-12-18 2017-06-21 Safeguard Biosystems Holdings Ltd. Three-dimensional polymer networks with channels situated therein
US11420174B2 (en) 2015-12-18 2022-08-23 Safeguard Biosystems Holdings Ltd. Three-dimensional polymer networks with channels situated therein
ES2962687T3 (es) 2015-12-29 2024-03-20 Galderma Holding SA Reticulación de carbohidratos
CN105606556B (zh) * 2016-01-28 2018-09-21 广西壮族自治区中医药研究院 马蹄蕨药材中多糖含量的紫外分光光度测定法
US10792477B2 (en) * 2016-02-08 2020-10-06 Orbusneich Medical Pte. Ltd. Drug eluting balloon
CA3022830A1 (en) 2016-04-20 2017-10-26 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device
EP3484535B1 (en) 2016-07-14 2022-01-19 Hollister Incorporated Hygienic medical devices having hydrophilic coating and methods of forming the same
US20190201580A1 (en) 2016-08-31 2019-07-04 Lifecell Corporation Breast treatment device
CN106474565A (zh) * 2016-12-09 2017-03-08 泰州学院 一种柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
US20180221021A1 (en) * 2017-02-08 2018-08-09 Ethicon, Inc. Braided suture with filament containing a medicant
JP2018153296A (ja) * 2017-03-16 2018-10-04 Jsr株式会社 不飽和化合物を含有する組成物
DE102017111486A1 (de) * 2017-05-17 2018-11-22 Phenox Gmbh Beschichtung für Medizinprodukte
CN112638436A (zh) 2018-05-22 2021-04-09 界面生物公司 用于将药物递送至血管壁的组合物和方法
WO2020112816A1 (en) 2018-11-29 2020-06-04 Surmodics, Inc. Apparatus and methods for coating medical devices
FR3089753B1 (fr) * 2018-12-13 2022-05-13 Franc Cecile Des gels bi-composants pour l’application contrôlée d’un traitement oxydant sur les surfaces
WO2020210647A2 (en) * 2019-04-12 2020-10-15 The Trustees Of Columbia University In The City Of New York Methods and compositions for protection of bioprosthetic heart valve tissue from glycation and associated protein incorporation
WO2020227095A1 (en) 2019-05-03 2020-11-12 Lifecell Corporation Breast treatment device
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
US12226552B2 (en) 2019-09-30 2025-02-18 Surmodics, Inc. Active agent depots formed in situ
US11235087B2 (en) 2019-10-28 2022-02-01 Galderma Holding SA Ready-to-use esthetic compositions
AU2020395955A1 (en) 2019-12-02 2022-07-14 Galderma Holding SA High molecular weight esthetic compositions
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
CN112618802B (zh) * 2020-12-08 2021-12-24 南方医科大学口腔医院 一种改善牙釉质脱矿的含氟抗菌隐形矫治器及其制备方法
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
US12496612B2 (en) 2021-01-08 2025-12-16 Surmodics, Inc. Coating application system and methods for coating rotatable medical devices
CN114452442A (zh) * 2022-01-30 2022-05-10 上海松力生物技术有限公司 一种原位诱导子宫壁组织再生的植入物
KR20230173613A (ko) * 2022-06-17 2023-12-27 주식회사 엘지화학 경화물의 제조방법 및 이에 따른 경화물
WO2024030418A2 (en) * 2022-08-02 2024-02-08 The Secant Group, Llc Biodegradable, elastomeric anastomotic tissue junction stabilizer
WO2025159745A1 (en) * 2024-01-24 2025-07-31 Bard Peripheral Vascular, Inc. Embolic hydrogels for female sterilization
USD1137672S1 (en) 2024-08-27 2026-07-28 Glaukos Corporation Drug eluting ocular implant
CN119736278B (zh) * 2024-12-19 2026-05-12 中国科学院上海硅酸盐研究所 一种用于催化缓释生物能量物质的生物酶及其固定方法

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US627899A (en) * 1897-07-03 1899-06-27 George Martin Brill Car-truck.
US2668156A (en) * 1950-04-06 1954-02-02 Nat Starch Products Inc Unsaturated starch compounds and insoluble derivatives thereof
US4060506A (en) * 1976-04-27 1977-11-29 A. E. Staley Manufacturing Company Starch acrylamides and the method for preparing the same
US4079025A (en) * 1976-04-27 1978-03-14 A. E. Staley Manufacturing Company Copolymerized starch composition
US4320221A (en) * 1980-12-12 1982-03-16 The Dow Chemical Company Addition polymerizable isocyanate-polyol anaerobic adhesives
US5160745A (en) 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US5116927A (en) * 1989-06-27 1992-05-26 Sequa Chemicals, Inc. Starch polymer graft composition and method of preparation
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5736371A (en) * 1991-06-04 1998-04-07 A Et S Biovecteurs Biodegradable particulate vector for transporting molecules having biological activity
WO1993009176A2 (en) 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
JP3455217B2 (ja) * 1992-02-13 2003-10-14 バイオ−メトリック システムズ インコーポレイテッド 架橋マトリックス中の化学種の固定
DE4210334A1 (de) * 1992-03-30 1993-10-07 Stoess & Co Gelatine Biologisch abbaubares, wasserresistentes Polymer-Material
US6277899B1 (en) * 1992-08-03 2001-08-21 Novamont S.P.A. Biodegradable polymeric composition
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US5414075A (en) 1992-11-06 1995-05-09 Bsi Corporation Restrained multifunctional reagent for surface modification
US5272181A (en) * 1992-11-18 1993-12-21 Evergreen Solutions, Inc. Biodegradable expanded foam material
NZ258533A (en) * 1992-11-30 1996-08-27 Ciba Geigy Ag Vinyl ester and amide derivatives of a dicarboxylic acid cyclic-oligomeric carbohydrate half ester; use for forming contact lenses, as thickeners, surfactants and lens cleaning agents
SE500964C2 (sv) * 1993-01-19 1994-10-10 Medicarb Ab Fast bärare med modifierad yta varvid modifikationen åstadkommes genom en primer innehållande en polysackarid och förfarande för framställning av en sådan bärare
US5589577A (en) * 1993-04-07 1996-12-31 Alko Group Ltd. Applications and methods for the preparation of fatty acid esters of polysaccharides
US5773021A (en) * 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
US5466233A (en) 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US5658592A (en) * 1994-05-13 1997-08-19 Kuraray Co., Ltd. Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery
TW362100B (en) 1995-07-21 1999-06-21 Novartis Ag The preparation and use of photochemically cross-linked polysaccharide derivatives having no photopolymerisable functional groups
JP2997995B2 (ja) * 1995-09-13 2000-01-11 日本コーンスターチ株式会社 生分解性樹脂組成物の水系分散液
US5714360A (en) * 1995-11-03 1998-02-03 Bsi Corporation Photoactivatable water soluble cross-linking agents containing an onium group
US5749848A (en) 1995-11-13 1998-05-12 Cardiovascular Imaging Systems, Inc. Catheter system having imaging, balloon angioplasty, and stent deployment capabilities, and method of use for guided stent deployment
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
ZA978537B (en) * 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
FR2753902B1 (fr) * 1996-09-27 1999-04-02 Ioualalen Karim Nouveau type de matrice ionique biodegradable de polarite interne modulable a polymere greffe
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
EP0842657A1 (en) 1996-11-19 1998-05-20 OctoPlus B.V. Microspheres for controlled release and processes to prepare these microspheres
IT1286510B1 (it) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
WO1998024483A2 (en) * 1996-12-03 1998-06-11 Osteobiologics, Inc. Biodegradable polymeric film
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same
US6121027A (en) * 1997-08-15 2000-09-19 Surmodics, Inc. Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups
US6316522B1 (en) * 1997-08-18 2001-11-13 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
DE19737481A1 (de) * 1997-08-28 1999-03-04 Hoechst Ag Sphärische lineare Polysaccharide enthaltende Mikropartikel
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
US6294644B1 (en) * 1998-03-06 2001-09-25 Ube Industries, Ltd. Nylon 12, nylon composition, method for producing nylon 12, and tubular molded product using nylon 12
US6410044B1 (en) * 1998-03-19 2002-06-25 Surmodics, Inc. Crosslinkable macromers
US6007833A (en) 1998-03-19 1999-12-28 Surmodics, Inc. Crosslinkable macromers bearing initiator groups
US6559257B2 (en) * 1998-06-12 2003-05-06 Lord Corporation Adhesive formulations
FR2780901B1 (fr) 1998-07-09 2000-09-29 Coletica Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
ATE297452T1 (de) * 1998-07-23 2005-06-15 Avebe Coop Verkoop Prod Klebemittelzusammensetzung
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6303047B1 (en) * 1999-03-22 2001-10-16 Lsi Logic Corporation Low dielectric constant multiple carbon-containing silicon oxide dielectric material for use in integrated circuit structures, and method of making same
ES2298135T3 (es) * 1999-04-12 2008-05-16 Cornell Research Foundation, Inc. Sistema formador de hidrogel con componentes hidrofobos e hidrofilos.
US6716445B2 (en) 1999-04-12 2004-04-06 Cornell Research Foundation, Inc. Hydrogel entrapping therapeutic agent and stent with coating comprising this
US6668935B1 (en) 1999-09-24 2003-12-30 Schlumberger Technology Corporation Valve for use in wells
AU2001271059A1 (en) * 2000-07-17 2002-01-30 Green Bio Inc. Biodegradable articles obtained from enzymatically synthesized amylose
ATE547080T1 (de) * 2000-08-30 2012-03-15 Univ Johns Hopkins Vorrichtungen zur intraokularen arzneimittelabgabe
SE517421C2 (sv) * 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
US6748954B2 (en) * 2000-10-27 2004-06-15 The Regents Of The University Of Michigan Drug release from polymer matrices through mechanical stimulation
US7595392B2 (en) * 2000-12-29 2009-09-29 University Of Iowa Research Foundation Biodegradable oxidized cellulose esters
US6586493B1 (en) * 2001-03-07 2003-07-01 Arizona Board Of Regents Arizona State University Polysaccharide-based hydrogels and pre-gel blends for the same
WO2002100453A1 (en) * 2001-06-07 2002-12-19 Surmodics, Inc. Crosslinkable macromers
US7501157B2 (en) * 2001-06-26 2009-03-10 Accelr8 Technology Corporation Hydroxyl functional surface coating
JP2005526972A (ja) 2002-05-02 2005-09-08 シファーゲン バイオシステムズ， インコーポレイテッド 多糖系ヒドロゲルをコーティングした表面を有するバイオチップ
DE10223310A1 (de) * 2002-05-24 2003-12-11 Biotronik Mess & Therapieg Verfahren zum Beschichten von Implantaten mit einer Polysaccharid-Lage
US7438925B2 (en) * 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
US7862831B2 (en) * 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US20040062778A1 (en) 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices
CA2689424A1 (en) 2002-09-29 2004-04-08 Surmodics, Inc. Methods for treatment and/or prevention of retinal disease
CA2509382A1 (en) * 2002-12-17 2004-07-08 Todd C. Zion Stimuli-responsive systems for controlled drug delivery
US20050025797A1 (en) * 2003-04-08 2005-02-03 Xingwu Wang Medical device with low magnetic susceptibility
US8021680B2 (en) * 2003-05-02 2011-09-20 Surmodics, Inc. Controlled release bioactive agent delivery device
WO2005113034A1 (en) * 2004-05-12 2005-12-01 Surmodics, Inc. Natural biodegradable polysaccharides coatings for medical articles
EP1778751B1 (en) * 2004-08-12 2017-03-01 Sherwin-Williams Luxembourg Investment Management Company S.à r.l. Carbohydrate based alkyds
CA2621595A1 (en) 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
WO2007038126A1 (en) 2005-09-21 2007-04-05 Surmodics, Inc. In vivo formed matrices including natural biodegradable polysaccharides and ophthalmic uses thereof

Similar Documents

Publication Publication Date Title
Hozumi et al. Injectable hydrogel with slow degradability composed of gelatin and hyaluronic acid cross-linked by Schiff’s base formation
Chircov et al. Hyaluronic acid-based scaffolds for tissue engineering
JP5226518B2 (ja) 天然の生分解性マトリックス、及びその使用
Smith et al. Polymer coatings for biomedical applications: a review
Shelke et al. Polysaccharide biomaterials for drug delivery and regenerative engineering
CN109939272B (zh) 一种抗凝血材料及其制备方法
Bae et al. Injectable biodegradable hydrogels: progress and challenges
Wang Overview on biocompatibilities of implantable biomaterials
Onuki et al. A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response
Dang et al. Multifunctional polyurethane materials in regenerative medicine and tissue engineering
Mishra et al. Preparation, properties and application of hydrogels: a review
Chen et al. The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents
CA2564588A1 (en) Natural biodegradable polysaccharide coatings for medical articles
Selvaraj et al. Biomedical potential of hydrogels: a multifaceted approach to innovative medication delivery
Zilberman et al. Drug-eluting medical implants
Kishida et al. Hydrogels for biomedical and pharmaceutical applications
CN103691007A (zh) 一种温敏水凝胶复合涂层血管支架的制备方法
Ren et al. Research and prospects of strategies for surface-modified coatings on blood-contacting materials
CN108578772A (zh) 一种用于提升生物相容性的血液接触材料制备方法及血液接触材料
Malone-Povolny et al. Combination of nitric oxide release and surface texture for mitigating the foreign body response
Sarangi et al. Interpenetrating polymer network based hydrogel: A smart approach for corroborating wound healing of various capacity
Yamamoto et al. Growth factor release from gelatin hydrogel for tissue engineering
Zou et al. Progress in the design principle of biomedical tissue adhesive hydrogel with naturally derived substance
Tamnna et al. Advances in polymer-based scaffolding for enhanced wound healing: a comprehensive review
Preetam et al. Bioactive coatings for cardiovascular stents: Modulating immune response for enhanced performance